Dongkyu Jeon
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Nutrient Availability Dictates Cancer Metabolism-Based Therapeutic Responses to Nononcology Drugs.
Journal: Cancer research
Published: March 12, 2025
Synthetic Strategies for Improving Solubility: Optimization of Novel Pyrazolo[1,5-a]pyrimidine CFTR Activator That Ameliorates Dry Eye Disease.
Journal: Journal of medicinal chemistry
Published: December 27, 2022
Inhibition of ANO1 by Cis- and Trans-Resveratrol and Their Anticancer Activity in Human Prostate Cancer PC-3 Cells.
Journal: International journal of molecular sciences
Published: December 12, 2022
Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine-Induced Dry Eye Mice.
Journal: International journal of molecular sciences
Published: March 24, 2022
VI-116, A Novel Potent Inhibitor of VRAC with Minimal Effect on ANO1.
Journal: International journal of molecular sciences
Published: March 16, 2022
Cinobufagin Exerts Anticancer Activity in Oral Squamous Cell Carcinoma Cells through Downregulation of ANO1.
Journal: International journal of molecular sciences
Published: October 06, 2021
Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition.
Journal: Cell reports
Published: July 05, 2021
Novel ANO1 Inhibitor from Mallotus apelta Extract Exerts Anticancer Activity through Downregulation of ANO1.
Journal: International journal of molecular sciences
Published: July 20, 2020
Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2.
Journal: International journal of molecular sciences
Published: May 21, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026